Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9567	Companies
189140	Keywords
120841	Articles
100922	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 11/13/2025 at 06:30, 1 month 9 days ago

Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025
Formycon AG publishes nine-month results, reaffirms 2025 guidance with strong pipeline progress and partnerships. Read about fiscal performance and strategic advancements

Formycon AG Partnerships Pipeline Progress Nine-month Results 2025 Guidance
BRIEF

published on 10/30/2025 at 06:35, 1 month 23 days ago

Formycon AG programme une conférence téléphonique sur ses résultats 2025 et les relations avec les investisseurs.

Résultats Financiers Formycon AG Conférence Téléphonique Conférences D'investisseurs Biosimilaires
BRIEF

published on 10/30/2025 at 06:35, 1 month 23 days ago

Formycon AG Schedules Conference Call for 2025 Results and Investor Engagement

Financial Results Conference Call Investor Conferences Formycon AG Biosimilars
PRESS RELEASE

published on 10/30/2025 at 06:30, 1 month 23 days ago

Formycon invites to Conference Call on 2025 Nine-Month Results and announces Participation in Investor Conferences in the 4th Quarter of 2025
Formycon AG to discuss 2025 Nine-Month Results in Conference Call and participate in Investor Conferences. Company specializes in biosimilars for various disease areas

Financial Results Conference Call Investor Conferences Formycon AG Biosimilars
BRIEF

published on 10/21/2025 at 06:35, 2 months 1 day ago

Formycon Launches Europe’s First Ranibizumab Biosimilar in Pre-filled Syringe

Teva Pharmaceuticals Ranibizumab Biosimilar Pre-filled Syringe FYB201/Ranivisio® Formycon Launch
BRIEF

published on 10/21/2025 at 06:35, 2 months 1 day ago

Formycon lance le premier biosimilaire du ranibizumab en seringue préremplie en Europe

Teva Pharmaceuticals FYB201/Ranivisio® Biosimilaire Du Ranibizumab Seringue Préremplie Lancement De Formycon
PRESS RELEASE

published on 10/21/2025 at 06:30, 2 months 1 day ago

Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe
Formycon's FYB201/Ranivisio® is Europe's First Ranibizumab Biosimilar available in Pre-filled Syringe, offering improved handling, accuracy, and convenience for applicants. Teva to commercialize across Europe

Europe Biosimilar Formycon Teva Ranivisio
BRIEF

published on 10/16/2025 at 06:35, 2 months 6 days ago

Actor Pharmaceuticals and Megalabs Partner for FYB203 Commercialization

Formycon AG Eylea® Biosimilar Actor Pharmaceuticals Megalabs FYB203 Commercialization
BRIEF

published on 10/16/2025 at 06:35, 2 months 6 days ago

Actor Pharmaceuticals et Megalabs s'associent pour la commercialisation du FYB203

Formycon AG Biosimilaire Eylea® Megalabs Acteur Pharmaceutique Commercialisation Du FYB203
PRESS RELEASE

published on 10/16/2025 at 06:30, 2 months 6 days ago

Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
Actor Pharmaceuticals and Megalabs to commercialize Formycon's Eylea biosimilar FYB203 in Australia and Latin America. Partnership agreements include upfront payments and royalties

Partnerships Commercialization Biosimilar Formycon Eylea

Accesswire

Published on 12/22/2025 at 15:00, 4 hours 56 minutes ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 5 hours 16 minutes ago

Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 5 hours 26 minutes ago

Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 5 hours 56 minutes ago

Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 5 hours 56 minutes ago

PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 19:31, 25 minutes ago

EQS-Adhoc: Marley Spoon Group SE: CEO Daniel Raab Re-appointed and Contract to be Extended until June 2029
Published on 12/22/2025 at 19:00, 56 minutes ago

PATRIMOINE ET COMMERCE: Déclarations des transactions sur actions propres (hors contrat de liquidité) réalisées le 19 décembre 2025
Published on 12/22/2025 at 18:51, 1 hour 4 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/22/2025 at 18:20, 1 hour 35 minutes ago

CGTN: How China drives high-quality development through technological innovation
Published on 12/22/2025 at 18:14, 1 hour 41 minutes ago

Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule

Les Echos

Published on 12/22/2025 at 18:33, 1 hour 23 minutes ago

ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 hour 51 minutes ago

Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 1 hour 51 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 2 hours 11 minutes ago

Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 2 hours 21 minutes ago

DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025

View all LES ECHOS COMFI WIRE